These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2968189)

  • 1. Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal lesion development in Sprague-Dawley rats by dehydroepiandrosterone.
    Weber E; Moore MA; Bannasch P
    Carcinogenesis; 1988 Jul; 9(7):1191-5. PubMed ID: 2968189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement and phenotypic modulation of N-nitrosomorpholine-induced hepatocarcinogenesis by dehydroepiandrosterone.
    Metzger C; Bannasch P; Mayer D
    Cancer Lett; 1997 Dec; 121(2):125-31. PubMed ID: 9570349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and modulation of hepatic preneoplasia and neoplasia in the rat by dehydroepiandrosterone.
    Mayer D; Forstner K; Kopplow K
    Toxicol Pathol; 2003; 31(1):103-12. PubMed ID: 12597454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine.
    Weber E; Moore MA; Bannasch P
    Carcinogenesis; 1988 Jun; 9(6):1049-54. PubMed ID: 2967125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine.
    Weber E; Bannasch P
    Carcinogenesis; 1994 Jun; 15(6):1235-42. PubMed ID: 8020161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement by isoproterenol of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
    Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M
    Int J Cancer; 1993 Feb; 53(4):703-6. PubMed ID: 8382197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. From basophilic areas of hepatocytes to hepatocellular tumors.
    Cortinovis C; Klimek F; Nogueira E
    Am J Pathol; 1991 Nov; 139(5):1157-71. PubMed ID: 1951631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by shi-quan-da-bu-tang (TJ-48) of experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
    Tatsuta M; Iishi H; Baba M; Nakaizumi A; Uehara H
    Eur J Cancer; 1994; 30A(1):74-8. PubMed ID: 8142169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone.
    Metzger C; Mayer D; Hoffmann H; Bocker T; Hobe G; Benner A; Bannasch P
    Toxicol Pathol; 1995; 23(5):591-605. PubMed ID: 8578102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats.
    Moore MA; Thamavit W; Tsuda H; Sato K; Ichihara A; Ito N
    Carcinogenesis; 1986 Feb; 7(2):311-6. PubMed ID: 2868807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement by ethyl alcohol of experimental hepatocarcinogenesis induced by N-nitrosomorpholine.
    Tatsuta M; Iishi H; Baba M; Yano H; Iseki K; Uehara H; Nakaizumi A
    Int J Cancer; 1997 Jun; 71(6):1045-8. PubMed ID: 9185709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of hepatocarcinogenesis in rats by dietary fructose.
    Enzmann H; Ohlhauser D; Dettler T; Bannasch P
    Carcinogenesis; 1989 Jul; 10(7):1247-52. PubMed ID: 2567639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement by neurotensin of hepatocarcinogenesis by N-nitrosomorpholine in Sprague-Dawley rats.
    Nakaizumi A; Uehara H; Baba M; Iishi H; Tatsuta M
    Cancer Lett; 1996 Dec; 110(1-2):57-61. PubMed ID: 9018081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-nitroso-2,6-dimethylmorpholine-induced hemangiosarcomas in the livers of randombred guinea pigs.
    Rao MS; Scarpelli DG; Lijinsky W
    J Natl Cancer Inst; 1980 Mar; 64(3):529-32. PubMed ID: 6928237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-dependent, tissue-specific opposing effects of dehydroepiandrosterone on initiation and modulation stages of liver and lung carcinogenesis induced by dihydroxy-di-n-propylnitrosamine in F344 rats.
    Moore MA; Weber E; Thornton M; Bannasch P
    Carcinogenesis; 1988 Aug; 9(8):1507-9. PubMed ID: 2969783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonographic evidence of phenotypic instability during hepatocarcinogenesis in N-nitrosomorpholine-treated rats.
    Oh JY; Jeong JS; Kim YJ; Nam KJ; Park BH; Kwon EY; Kim YH; Hwang TH
    Exp Mol Pathol; 2002 Aug; 73(1):67-73. PubMed ID: 12127056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of hepatocellular carcinoma with high metastatic potential in WS/Shi rats: discovery of an inbred strain highly susceptible to the liver carcinogen N-nitrosomorpholine.
    Murai T; Mori S; Hosono M; Iwakura Y; Takashima A; Oohara T; Makino S; Takeda R; Fukushima S
    Oncol Res; 2000; 12(3):121-6. PubMed ID: 11216670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by cysteamine of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
    Tatsuta M; Iishi H; Baba M
    Int J Cancer; 1989 Sep; 44(3):529-33. PubMed ID: 2570757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention by amiloride against experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
    Tatsuta M; Iishi H; Baba M; Yano H; Sakai N; Uehara H; Nakaizumi A
    Cancer Lett; 1997 Oct; 119(1):109-13. PubMed ID: 18372529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenesis in rats by nitrosodimethylamine and other nitrosomethylalkylamines at low doses.
    Lijinsky W; Reuber MD
    Cancer Lett; 1984 Feb; 22(1):83-8. PubMed ID: 6538112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.